FDA approves cidofovir for treatment of CMV retinitis. Food and Drug Administration.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000503:physiopathology; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D018450:Disease Progression; D017277:Drug Approval; D006801:Humans; D007668:Kidney / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents